Generic policy in Bulgaria: a policy of failure or success?

A Stoimenova, S Penkov, A Savova… - Biotechnology & …, 2016 - Taylor & Francis
Generic medicines play a key role in managing the financial resources for pharmaceuticals
in every country. This study analysed the generic policy legislative framework in Bulgaria …

Аn affordability of statins therapy-comparative analysis between Ukraine and Bulgaria

O Tkachova, L Iakovlieva, Z Mitkova, M Manova… - BMC Health Services …, 2019 - Springer
Background The statins are а developing group of cardiovascular medicines, widely used
for dyslipidemia. As a whole statins consumption leads to reduction in cardiovascular events …

Cost-effectiveness of biphasic insulin aspart 30 vs. human premix insulin in type 2 diabetes from the payer's perspective in Bulgaria

V Valov, J Palmer, M Czech, A Savova… - Biotechnology & …, 2012 - Taylor & Francis
The aim of this study was to assess the long-term cost-effectiveness of biphasic insulin
aspart 30 versus human premix insulin in patients with type 2 diabetes from a third-party …

Evaluation of statin utilization in the Republic of Macedonia during 2013–2016

Z Naumovska, AK Nestorovska… - ClinicoEconomics …, 2018 - Taylor & Francis
Purpose A rational use of statins has a major and increasing importance in public health and
allocation of financial resources by the health insurance funds (HIFs). The aim of this study …

Economic impact of the highly active antiretroviral pharmacotherapy on cost and HIV/AIDS control in Bulgaria

M Dimitrova, G Petrova, M Manova… - Biotechnology & …, 2013 - Taylor & Francis
The objective of this study was to analyze the changes in the antiretroviral pharmacotherapy
during the period 2006–2011 and its impact on the cost and disease control of HIV/AIDS in …

Impact of price deregulation policy on the affordability of essential medicines for women's health: a panel data analysis

J Liu, L Wang, C Liu, X Zhang - Expert Review of …, 2017 - Taylor & Francis
Background: A new policy which required deregulation on prices of off-patent medicines for
women's health during procurement was introduced in China in September 2015. The …

Chirality as a Patent Protection Policy—An Example with Citalopram

L Peikova, M Manova, I Pencheva… - Biotechnology & …, 2012 - Taylor & Francis
The aim of this study was to analyze the patent protection policy of Citalopram as an
example for protection of a biologically active chiral structure. A three-step search …

ДОСТЪПНОСТ И РЕИМБУРСИРАНЕ НА ТЕРАПИЯТА С АНТИХИПЕРЛИПИДЕМИЧНИ ЛЕКАРСТВЕНИ ПРОДУКТИ В БЪЛГАРИЯ

Г Ковачка, Н Герасимов… - Medical Review …, 2020 - search.ebscohost.com
Сърдечно-съдовите заболявания са водещи по заболяемост и смъртност в голям брой
държави. Хиперхолестеролемия се наблюдава при над 50% от пациентите с остър …

[PDF][PDF] iNtellectUAl PrOPertY riGHtS

L Peikova, M Manova, I Pencheva, G Petrova - researchgate.net
The aim of this study was to analyze the patent protection policy of citalopram as an example
for protection of a biologically active chiral structure. A three-step search methodology of …

[PDF][PDF] СПИСАНИЕ НА БЪЛГАРСКОТО НАУЧНО ДРУЖЕСТВО ПО ФАРМАЦИЯ Главен редактор: Ст. Николов

З Димитрова, С Богданова, И Иванов, Г Китанов… - ФАРМАЦИЯ, 2011 - researchgate.net
As continuance of some previous investigations, a series of twenty five new hydrazones
representing derivatives of pyrrole were synthesized and structurally elucidated. New …